INFORMATIONAL PURPOSES ONLY. Not medical, legal, or travel advice. Verify with official sources before acting. See corrections log.
Regenerative medicine laws and requirements in North Carolina. Citations, verification dates, and source links for every data point.
| Dimension | Value | Citation | Source | Verified | Confidence |
|---|---|---|---|---|---|
| Permit Unapproved Cell Therapies | permit cell therapies | N.C. Gen. Stat. § 90-325.1 et seq. (Right to Try Act, as amended by H.B. 934, 2019)“The North Carolina SCI Medical Freedom law [H.934 (2019)] amended the State’s RTT Act (NC G.S.§90–325.1–2, 6–7) and added a new section (NC G.S.§90–325.15–22) to allow patients access to investigational stem cell therapies.”Note: Access to investigational adult stem cell treatments (in clinical trials, not FDA approved) for severe chronic disease or terminal illness. Official NC statute site (ncleg.gov) blocked automated access (403/Cloudflare) during this pass; evidence is a peer-reviewed review. Primary text not read. | Link | 2026-10-09 | medium |
| Require Patient Disclosure for Cell Therapies | require disclosure | N.C. Gen. Stat. § 90-325.1 et seq. (H.B. 934, 2019)“Written informed consent must include an explanation of currently approved treatments for the patient’s illness; attestation that patient believes current treatments are insufficient; identification of the specific class of investigational SCI;”Note: Statutory written informed consent; no posted/advertising notice. Official NC statute site (ncleg.gov) blocked automated access (403/Cloudflare) during this pass; evidence is a peer-reviewed review. Primary text not read. | Link | 2026-10-09 | medium |
| Limit Practitioner Scope for Cell Therapies | Physician must administer; protocol approved by an IRB (affiliated with a medical school or its affiliated facility), with annual IRB reports to the NC Medical Board. | N.C. Gen. Stat. § 90-325.1 et seq. (H.B. 934, 2019)“The law requires that a physician administers the SCI, that the protocol be approved by an IRB, and that an annual report be sent to the state medical board by the IRB.”Note: IRB affiliation detail from the review's Table 2 ('IRB must be affiliated with a medical school or an affiliated facility of a medical school'). Official NC statute site (ncleg.gov) blocked automated access (403/Cloudflare) during this pass; evidence is a peer-reviewed review. Primary text not read. | Link | 2026-10-09 | medium |
| Have Cell Therapy Statute References | N.C. Gen. Stat. § 90-325.1 et seq. (Right to Try Act, as amended by H.B. 934, 2019) | N.C. Gen. Stat. § 90-325.1 et seq.“The North Carolina SCI Medical Freedom law [H.934 (2019)] amended the State’s RTT Act (NC G.S.§90–325.1–2, 6–7) and added a new section (NC G.S.§90–325.15–22) to allow patients access to investigational stem cell therapies.”Note: Exact section numbers of the stem cell part could not be confirmed from the official site (sources differ); cite the Act generally. Official NC statute site (ncleg.gov) blocked automated access (403/Cloudflare) during this pass; evidence is a peer-reviewed review. Primary text not read. | Link | 2026-10-09 | medium |
View full North Carolina profile (all layers) · Report an error on this page